104 related articles for article (PubMed ID: 9873558)
1. Solid-phase synthesis of potential protein tyrosine phosphatase inhibitors via the Ugi four-component condensation.
Li Z; Yeo SL; Pallen CJ; Ganesan A
Bioorg Med Chem Lett; 1998 Sep; 8(18):2443-6. PubMed ID: 9873558
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of alpha,alpha-difluorobenzylphosphonic acid derivatives as small molecular inhibitors of protein-tyrosine phosphatase 1B.
Yokomatsu T; Murano T; Umesue I; Soeda S; Shimeno H; Shibuya S
Bioorg Med Chem Lett; 1999 Feb; 9(4):529-32. PubMed ID: 10098656
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of [difluoro-(3-alkenylphenyl)-methyl]-phosphonic acids on non-crosslinked polystyrene and their evaluation as inhibitors of PTP1B.
Hum G; Lee J; Taylor SD
Bioorg Med Chem Lett; 2002 Dec; 12(23):3471-4. PubMed ID: 12419386
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of a tyrphostin ether library.
Guo G; Arvanitis EA; Pottorf RS; Player MR
J Comb Chem; 2003; 5(4):408-13. PubMed ID: 12857109
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors.
Dixit M; Tripathi BK; Tamrakar AK; Srivastava AK; Kumar B; Goel A
Bioorg Med Chem; 2007 Jan; 15(2):727-34. PubMed ID: 17095232
[TBL] [Abstract][Full Text] [Related]
6. A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors.
Tulsi NS; Downey AM; Cairo CW
Bioorg Med Chem; 2010 Dec; 18(24):8679-86. PubMed ID: 21055952
[TBL] [Abstract][Full Text] [Related]
7. The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates.
Asante-Appiah E; Patel S; Dufresne C; Roy P; Wang Q; Patel V; Friesen RW; Ramachandran C; Becker JW; Leblanc Y; Kennedy BP; Scapin G
Biochemistry; 2002 Jul; 41(29):9043-51. PubMed ID: 12119018
[TBL] [Abstract][Full Text] [Related]
8. Optimization of three- and four-component reactions for polysubstituted piperidines: application to the synthesis and preliminary biological screening of a prototype library.
Ulaczyk-Lesanko A; Pelletier E; Lee M; Prinz H; Waldmann H; Hall DG
J Comb Chem; 2007; 9(4):695-703. PubMed ID: 17521171
[TBL] [Abstract][Full Text] [Related]
9. A two stage click-based library of protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2007 Jan; 15(1):458-73. PubMed ID: 17046267
[TBL] [Abstract][Full Text] [Related]
10. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
13. Naphthalenebis[alpha,alpha-difluoromethylenephosphonates] as potent inhibitors of protein tyrosine phosphatases.
Wang Q; Huang Z; Ramachandran C; Dinaut AN; Taylor SD
Bioorg Med Chem Lett; 1998 Feb; 8(4):345-50. PubMed ID: 9871682
[TBL] [Abstract][Full Text] [Related]
14. PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.
Cho SY; Baek JY; Han SS; Kang SK; Ha JD; Ahn JH; Lee JD; Kim KR; Cheon HG; Rhee SD; Yang SD; Yon GH; Pak CS; Choi JK
Bioorg Med Chem Lett; 2006 Feb; 16(3):499-502. PubMed ID: 16289879
[TBL] [Abstract][Full Text] [Related]
15. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
Kole HK; Smyth MS; Russ PL; Burke TR
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
[TBL] [Abstract][Full Text] [Related]
16. [Development of Biologically Active Compounds on the Basis of Phosphonic and Phosphinic Acid Functionalities].
Yokomatsu T
Yakugaku Zasshi; 2017; 137(9):1051-1086. PubMed ID: 28867694
[TBL] [Abstract][Full Text] [Related]
17. Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases.
Kotoris CC; Chen MJ; Taylor SD
Bioorg Med Chem Lett; 1998 Nov; 8(22):3275-80. PubMed ID: 9873717
[TBL] [Abstract][Full Text] [Related]
18. A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
Swierczek K; Pandey AS; Peters JW; Hengge AC
J Med Chem; 2003 Aug; 46(17):3703-8. PubMed ID: 12904075
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2.
Hamaguchi T; Takahashi A; Kagamizono T; Manaka A; Sato M; Osada H
Bioorg Med Chem Lett; 2000 Dec; 10(23):2657-60. PubMed ID: 11128645
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
